Join us in marking a major milestone, our 10,000th blood and marrow transplant patient! From our first transplant in 1989 to becoming the largest program in the Southeast, Moffitt’s Blood and Marrow Transplant and Cellular Immunotherapy team has built a legacy of healing.

we hit the 500 #pae mark today!!!! what a fun milestone to celebrate with the entire #IRAD team! thanks to the RNs for getting me a cake! couldn’t be more proud of the unique #pae program in prostate cancer that we’re building here @MoffittNews

Our privilege @uciradiology to host @NaineshParikhMD last week for an outstanding Grand Rounds on the emerging roles for Prostatic Artery Embolization in the setting of prostate cancer before and after radiation therapy #PAE #IRAD @SIRspecialists @SIRRFS

Strong 💪🏻 work from a stellar resident @celinachiodo presenting @MoffittNews early experience with online hypofx adaptive bladder radiation. Awesome support by @MoffittRadOnc physics in making this an option for our patients

what an exciting time to be on the @MoffittNews team!

Live @MountSinaiIR big thanks to our Grand Rounds Speaker @NaineshParikhMD for sharing insights on the #BusinessGrowth strategy for #IRAD @SIRspecialists @SIRRFS

From our first transplant in 1989 to our 10,000th today 🎉 We celebrated with our faculty, nurses, pharmacists & APPs (photo: faculty), with deepest gratitude to the patients & families who entrust us with their care. @MoffittNews

Excited to share a great podcast I did with @RenaMalikMD about a big passion of mine : #prostate embolization ! #PAE #menshealth https://t.co/D2t44YDUxm How One Simple Procedure Can Save You from Prostate Surgery Forever @MountSinaiIR @SIRspecialists

72 yo man pre pae: - PV 128cc - IPSS/QoL 10/4 - alpha blockade causing major dizziness - PCa on active surveillance - annual biopsies cause AUR post pae: - PV 38cc (70% PV reduction! 😮😲) - IPSS/QoL 1/1 off meds LOVE when this happens for cancer patients! #irad #pae

An innovative approach that had a real impact on our prostate cancer patient’s QOL. PAE also converted 52% of patients initially contraindicated for brachytherapy/SBRT without an impact on local control! Amazing work @VaseemKhatri ! @MoffittNews

post PAE IPSS/QoL improvement persists post-RT

HOT OFF THE PRESS! Neoadjuvant PAE prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation - https://t.co/uk9rtTBJuO @MoffittNews @MoffittRadOnc @KOSJ12 @gdgrass @VaseemKhatri @ctRO_journal

should be an AWESOME outcome #irad

We are excited to announce that Nainesh Parikh, MD, (@NaineshParikhMD), has been named vice president and Chief Clinical Expansion and Partnerships officer! In this role, he will lead efforts to bring care closer to patients and build partnerships with like-minded organizations.

Explore this 2024 IO topic with Dr. @NaineshParikhMD on Prostate Artery Embolization: https://t.co/55Sb7u0FtR Join us at #CIO2025 in Miami, Oct. 17-19, for 80+ presentations, Y90 Pre-Conference on Oct. 16, & top IO experts. Tier 2 rates are limited, so register today:

68 yo woman with breast cancer and progressive adhesive capsulitis - my friend and colleague @alroubaieMD performed what might be the tampa region’s first adhesive capsulitis embo! nice technical outcome! she should do well! @MoffittNews #irad

thanks so much for inviting me to speak about this!

i know glue is all the rage but check out the staining in the L hemiprostate using particles during an injection from the RPA…159cc gland, used 36cc total (21cc on the left)! #irad #perfected

thank you @BIDMCRad @BIDMCRad for having me for grand rounds! what an honor and what an excellent discussion!

Leveraging technology to improve cross-stakeholder collaboration and patient outcomes – @CancerXMoonshot @NaineshParikhMD @PaulLandau74 @kamalj83 https://t.co/M7ScRN3GNz #CancerX #PatientOutcomes #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews @CancerWorldmag